SEEL logo

Seelos Therapeutics (SEEL) Non Current Assets

Annual Non Current Assets

$15.00 K
-$57.00 K-79.17%

December 31, 2023

Summary

Performance

1-Year Change

-79.17%

3-Year Change

+100%

5-Year Change

-80%

15-Year Change

-86.84%

SEEL Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.23%
SEEL annual long term assets is higher than 3.23% of companies in Healthcare sector

High & Low

All-time High

$19.17 M
SEEL annual long term assets is currently -99.92% below its historical high of $19.17 million

3-Year Low

$15.00 K
SEEL annual long term assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Annual Total Assets

$5.42 M
SEEL annual total assets is $5.42 million

Annual Current Assets

$5.40 M
SEEL annual total current assets is $5.40 million

Annual Total Liabilities

$38.93 M
SEEL annual total liabilities is $38.93 million

Annual Total Long Term Liabilities

$0.00
SEEL annual total long term liabilities is $0.00

Quarterly Non Current Assets

$47.00 K
-$15.00 K-24.19%

June 30, 2024

Summary

Performance

3-Month Change

-24.19%

1-Year Change

+56.67%

3-Year Change

-34.72%

5-Year Change

+95.83%

SEEL Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.78%
SEEL quarterly long term assets is higher than 4.78% of companies in Healthcare sector

High & Low

All-time High

$19.37 M
SEEL quarterly long term assets is currently -99.76% below its historical high of $19.37 million

3-Year Low

$0.00
SEEL quarterly long term assets is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Quarterly Total Assets

$2.38 M
SEEL quarterly total assets is $2.38 million

Quarterly Current Assets

$2.33 M
SEEL quarterly total current assets is $2.33 million

Quarterly Total Liabilities

$30.51 M
SEEL quarterly total liabilities is $30.51 million

Quarterly Long Term Liabilities

$0.00
SEEL quarterly total long term liabilities is $0.00

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

SEEL Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-79.2%+56.7%
3 y3 years+100.0%-34.7%
5 y5 years-80.0%+95.8%

SEEL Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.2%at low-34.7%-100.0%
5 y5-year-79.2%-100.0%-36.5%-100.0%
alltimeall time-99.9%-100.0%-99.8%-100.0%

Seelos Therapeutics Non Current Assets History

DateAnnualQuarterly
Jun 2024
-
$47.00 K(-24.2%)
Mar 2024
-
$62.00 K(+313.3%)
Dec 2023
$5.40 M(-76.2%)
$15.00 K(-50.0%)
Sep 2023
-
$30.00 K(-31.8%)
Jun 2023
-
$44.00 K(-24.1%)
Mar 2023
-
$58.00 K(-19.4%)
Dec 2022
$22.67 M(-72.8%)
$72.00 K(>+9900.0%)
Sep 2022
-
$0.00(-100.0%)
Jun 2022
-
$13.00 K(-50.0%)
Mar 2022
-
$26.00 K(-33.3%)
Dec 2021
$83.46 M(+377.1%)
$39.00 K(-23.5%)
Sep 2021
-
$51.00 K(-19.0%)
Jun 2021
-
$63.00 K(-14.9%)
Mar 2021
-
$74.00 K(>+9900.0%)
Dec 2020
$17.49 M(+57.7%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
Dec 2019
$11.10 M(+201.1%)
$0.00(0.0%)
Sep 2019
-
$0.00(-100.0%)
Jun 2019
-
$24.00 K(0.0%)
Mar 2019
-
$24.00 K(-68.0%)
Dec 2018
$3.69 M(-44.1%)
$75.00 K(-9.6%)
Sep 2018
-
$83.00 K(-9.8%)
Jun 2018
-
$92.00 K(-9.8%)
Mar 2018
-
$102.00 K(-10.5%)
Dec 2017
$6.59 M(+81.4%)
$114.00 K(-15.6%)
Sep 2017
-
$135.00 K(-18.7%)
Jun 2017
-
$166.00 K(-19.8%)
Mar 2017
-
$207.00 K(-80.6%)
Dec 2016
$3.63 M(-41.5%)
$1.07 M(-9.2%)
Sep 2016
-
$1.17 M(-5.4%)
Jun 2016
-
$1.24 M(-5.5%)
Mar 2016
-
$1.31 M(-16.0%)
Dec 2015
$6.22 M(-53.2%)
$1.56 M(+9.0%)
Sep 2015
-
$1.44 M(-8.8%)
Jun 2015
-
$1.57 M(-1.7%)
Mar 2015
-
$1.60 M(+5.4%)
Dec 2014
$13.29 M(-40.3%)
$1.52 M(+6.7%)
Sep 2014
-
$1.43 M(-1.9%)
Jun 2014
-
$1.45 M(-0.1%)
Mar 2014
-
$1.45 M(+38.9%)
Dec 2013
$22.26 M(+6.6%)
$1.05 M(+63.7%)
Sep 2013
-
$639.00 K(+5.8%)
Jun 2013
-
$604.00 K(-42.2%)
Mar 2013
-
$1.04 M(-65.0%)
Dec 2012
$20.89 M(+155.1%)
$2.98 M(-78.7%)
Sep 2012
-
$14.00 M(+48.1%)
Jun 2012
-
$9.45 M(+8.0%)
Mar 2012
-
$8.75 M(+3.9%)
DateAnnualQuarterly
Dec 2011
$8.19 M(-21.8%)
$8.42 M(+82.0%)
Sep 2011
-
$4.63 M(-1.9%)
Jun 2011
-
$4.72 M(-42.3%)
Mar 2011
-
$8.18 M(-2.4%)
Dec 2010
$10.48 M(+492.9%)
$8.39 M(-55.0%)
Sep 2010
-
$18.65 M(-3.7%)
Jun 2010
-
$19.37 M(+1.8%)
Mar 2010
-
$19.02 M(-0.8%)
Dec 2009
$1.77 M(-40.0%)
$19.17 M(+283.6%)
Sep 2009
-
$5.00 M(-1.8%)
Jun 2009
-
$5.09 M(-1.3%)
Mar 2009
-
$5.16 M(-8.1%)
Dec 2008
$2.95 M(-20.0%)
$5.61 M(-15.8%)
Sep 2008
-
$6.66 M(-1.7%)
Jun 2008
-
$6.78 M(-1.2%)
Mar 2008
-
$6.86 M(-1.9%)
Dec 2007
$3.68 M(-70.4%)
$6.99 M(-1.3%)
Sep 2007
-
$7.08 M(-1.6%)
Jun 2007
-
$7.20 M(-1.6%)
Mar 2007
-
$7.32 M(-2.3%)
Dec 2006
$12.45 M(+181.7%)
$7.49 M(-2.6%)
Sep 2006
-
$7.69 M(-6.4%)
Jun 2006
-
$8.21 M(-2.8%)
Mar 2006
-
$8.45 M(-5.2%)
Dec 2005
$4.42 M(-58.0%)
$8.91 M(-2.3%)
Sep 2005
-
$9.13 M(-2.4%)
Jun 2005
-
$9.35 M(-2.4%)
Mar 2005
-
$9.58 M(-1.7%)
Dec 2004
$10.53 M(-15.8%)
$9.74 M(-2.2%)
Sep 2004
-
$9.96 M(-2.0%)
Jun 2004
-
$10.17 M(-2.1%)
Mar 2004
-
$10.38 M(-2.3%)
Dec 2003
$12.51 M(+450.8%)
$10.62 M(-3.7%)
Sep 2003
-
$11.04 M(-2.8%)
Jun 2003
-
$11.35 M(-1.3%)
Mar 2003
-
$11.50 M(-3.1%)
Dec 2002
$2.27 M(-88.4%)
$11.87 M(+0.4%)
Sep 2002
-
$11.82 M(+7.0%)
Jun 2002
-
$11.05 M(+16.1%)
Mar 2002
-
$9.52 M(+23.8%)
Dec 2001
$19.62 M(-46.4%)
$7.69 M(+27.8%)
Sep 2001
-
$6.02 M(+12.4%)
Jun 2001
-
$5.36 M(+18.4%)
Mar 2001
-
$4.53 M(+33.2%)
Dec 2000
$36.59 M(+401.3%)
$3.40 M(+302.4%)
Sep 2000
-
$844.20 K(+37.9%)
Jun 2000
-
$612.10 K(+30.1%)
Mar 2000
-
$470.50 K
Dec 1999
$7.30 M(+3506.7%)
-
Dec 1997
$202.40 K
-

FAQ

  • What is Seelos Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Seelos Therapeutics?
  • What is Seelos Therapeutics annual non current assets year-on-year change?
  • What is Seelos Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly non current assets year-on-year change?

What is Seelos Therapeutics annual long term assets?

The current annual non current assets of SEEL is $15.00 K

What is the all time high annual non current assets for Seelos Therapeutics?

Seelos Therapeutics all-time high annual long term assets is $19.17 M

What is Seelos Therapeutics annual non current assets year-on-year change?

Over the past year, SEEL annual long term assets has changed by -$57.00 K (-79.17%)

What is Seelos Therapeutics quarterly long term assets?

The current quarterly non current assets of SEEL is $47.00 K

What is the all time high quarterly non current assets for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly long term assets is $19.37 M

What is Seelos Therapeutics quarterly non current assets year-on-year change?

Over the past year, SEEL quarterly long term assets has changed by +$17.00 K (+56.67%)